GAS5 and Hyperglycemia: Combined these results suggest a mechanism of hyperglycemia-mediated chronic inflammation that involves the dysregulation of GAS5 expression, leading to elevated production of pro-inflammatory (M1-like) macrophages and abnormal fibroblasts.